Major u-turn sees Roche’s Kadcyla backed for NHS use

16th June 2017 Uncategorised 0

In a major turnaround Roche’s Kadcyla will now become routinely available on the NHS to some patients with breast cancer after a confidential deal was reached between the drug giant and NHS England.

More: Major u-turn sees Roche’s Kadcyla backed for NHS use
Source: News